4-BROMO-2,6-DIFLUORO-BENZOIC ACID ETHYL ESTER, 95.0%, 1g

3,5-dibromo-1-(2,2-diethoxyethyl)-1H-1,2,4-triazole, 95.0%, 2g

11-Oxa-2,7,9-triazadodec-7-enoic acid, 3-carboxy-10-oxo-12-phenyl-8-[[(phenylmethoxy)carbonyl]amino]-, 1-(9H-fluoren-9-ylmethyl) ester, (3S)-, 100mg

Triphenyl[(tetrahydro-2H-pyran-4-yl)methyl]phosphonium iodide, 97%, 5g

4-(Benzyloxy)-2,6-difluorobenzaldehyde, 95.0%, 250mg

Benzothiazole-2,5-diamine, 95.0%, 1g

3-chloro-5-cyclopropyl-1,2,4-thiadiazole, 95.0%, 1g

Ethyl isopropyl sulfone, 98%, 500g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[tris(1-methylethyl)silyl]-1H-pyrrole, 95.0%, 1g

Thionyl chloride, min. 98%, for synthesis, 100 ml, glass packaging

4-(4-Fluoro-phenyl)-piperidine hydrochloride, 97.0%, 25g

5-bromo-2-chloro-1,4-dihydropyrimidin-4-one, 95+%, 250mg

Methyl 2-(4-methylphenylsulfonamido)acetate, 95.0%, 1kg